Marketing-authorisation holder · United States

Shorla

United States2 medicines1 country

2 medicines in 1 country, as authorisation holder.

Medicines

Every medicine in the registers under its name, current ones first.

2 medicines

Medicine	Substance	Country	Status	Authorised
JYLAMVO2mg/ml · Solution	Methotrexate	United States	Marketed	2022
TEPYLUTE100mg/10ml (10mg/ml) \| 15mg/1.5ml (10mg/ml) · Solution	Thiotepa	United States	Marketed	2024

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	2	2	0	Companies All medicines

The active substances in most of its medicines.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Marketing-authorisation holder · United States

United States2 medicines1 country

2 medicines in 1 country, as authorisation holder.

Every medicine in the registers under its name, current ones first.

2 medicines

Medicine	Substance	Country	Status	Authorised
JYLAMVO2mg/ml · Solution	Methotrexate	United States	Marketed	2022
TEPYLUTE100mg/10ml (10mg/ml) \| 15mg/1.5ml (10mg/ml) · Solution	Thiotepa	United States	Marketed	2024

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
United States	2	2	0	Companies All medicines

The active substances in most of its medicines.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

U.S. Food and Drug Administration (Drugs@FDA, openFDA)

Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.

Licence: Public domain (U.S. Government work)

Report an error or request removalCorrections from the company itself are welcome.

Ranked by their number of medicines.